在糖尿病病中,DOT1L通过类似C的脂酶1对细胞损伤进行保护
Yepeng Hu1, Shu Ye1, Jing Kong1
1Department of Endocrinology, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, Zhejiang, China.
Cell communication and signaling : CCS
|October 26, 2024
概括
破坏端粒沉默1样 (DOT1L) 破坏者通过上调脂酶C样1 (PLCL1) 来保护糖尿病病,改善细胞损伤和脂肪酸代谢.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 糖尿病病 (DKD) 的特点是细胞受伤,导致蛋白尿和血球硬化.
- 破坏端粒沉默1-like (DOT1L) 的破坏者,一个组分离子甲基转移酶,显示在预防纤维化方面具有潜力.
- DOT1L在糖尿病诱导的葡萄细胞损伤中的作用和机制需要进一步研究.
研究的目的:
- 为了研究DOT1L在糖尿病细胞损伤中的保护作用.
- 阐明DOT1L在DKD中的作用背后的分子机制.
主要方法:
- 评估了用西方涂抹和免疫光检测在细胞和脏组织中的DOT1L表达.
- 利用细胞培养 (MPC-5) 和小鼠模型 (db/db) 来研究DOT1L对细胞损伤的影响.
- 采用RNA测序来识别DOT1L目标基因,并进行分子实验来确认DOT1L对PLCL1的调节.
主要成果:
- 在高葡萄糖条件下和DKD模型中,DOT1L表达显著下降.
- 在db/db小鼠中,DOT1L上调保护细胞免受高葡萄糖诱导的亡和抑制损伤.
- DOT1L通过H3K79me2增加了脂酶C类1 (PLCL1) 的表达,PLCL1对DOT1L的保护作用至关重要.
- DOT1L改善了糖尿病小细胞中的异常脂肪酸代谢,这种效果取决于PLCL1.
结论:
- DOT1L通过通过PLCL1-介导的脂肪酸代谢调节来保护DKD中的细胞损伤.
- DOT1L代表了糖尿病病的潜在治疗标.
相关概念视频
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
464
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
464
01:11IP3/DAG Signaling Pathway
11.9K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
11.9K
01:30Peripheral Artery Disease I: Introduction
2
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs but also impacts other areas, such as the arms, thereby impairing overall circulation and organ function.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty deposits inside the arterial...
2